Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
three
months ended in Jun. 2026,
PTrana Meditama Metropolitan Tbk paidRp0 Mil more to buy back shares than it received from issuing new shares.
It spentRp57,250 Mil paying down its debt.
It paidRp0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It receivedRp0 Mil from paying cash dividends to shareholders.
It receivedRp0 Mil on other financial activities.
In all, PTrana Meditama Metropolitan TbkspentRp57,250 Mil on financial activities for the
three
months ended in Jun. 2026.
PTrana Meditama Metropolitan Tbk (ISX:SAME) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
PTrana Meditama Metropolitan Tbk's issuance of stock for the
three
months ended in Jun. 2026 was Rp0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
PTrana Meditama Metropolitan Tbk's repurchase of stock for the
three
months ended in Jun. 2026 was Rp0 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
PTrana Meditama Metropolitan Tbk's net issuance of debt for the
three
months ended in Jun. 2026 was Rp-57,250 Mil.
PTrana Meditama Metropolitan Tbk spentRp57,250 Mil paying down its debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
PTrana Meditama Metropolitan Tbk's net issuance of preferred for the
three
months ended in Jun. 2026 was Rp0 Mil.
PTrana Meditama Metropolitan Tbk paidRp0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
PTrana Meditama Metropolitan Tbk's cash flow for dividends for the
three
months ended in Jun. 2026 was Rp0 Mil.
PTrana Meditama Metropolitan Tbk receivedRp0 Mil from paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
PTrana Meditama Metropolitan Tbk's other financing for the
three
months ended in Jun. 2026 was Rp0 Mil.
PTrana Meditama Metropolitan Tbk receivedRp0 Mil on other financial activities.
PTrana Meditama Metropolitan Tbk Cash Flow from Financing Related Terms
PTrana Meditama Metropolitan Tbk Cash Flow from Financing Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PTrana Meditama Metropolitan Tbk Cash Flow from Financing Chart
PTrana Meditama Metropolitan Tbk Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp-131,729 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow from Financing of Rp-131,729 Mil mean?
PTrana Meditama Metropolitan Tbk (ISX:SAME) has a Cash Flow from Financing of Rp-131,729 Mil as of Jun. 2026. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for PTrana Meditama Metropolitan Tbk and its competitors.
Is PTrana Meditama Metropolitan Tbk's Cash Flow from Financing too high?
PTrana Meditama Metropolitan Tbk's current Cash Flow from Financing is Rp-131,729 Mil. Overall, PTrana Meditama Metropolitan Tbk has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PTrana Meditama Metropolitan Tbk's Cash Flow from Financing compare to HCA and THC?
PTrana Meditama Metropolitan Tbk's Cash Flow from Financing of Rp-131,729 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Healthcare Providers & Services company?
A good Cash Flow from Financing depends on the Healthcare Providers & Services industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for PTrana Meditama Metropolitan Tbk and its competitors. PTrana Meditama Metropolitan Tbk's current Cash Flow from Financing is Rp-131,729 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PTrana Meditama Metropolitan Tbk stock overvalued right now?
Based on GuruFocus' analysis, PTrana Meditama Metropolitan Tbk (ISX:SAME) is currently considered Fairly Valued. The stock's GF Value™ is Rp354.65, compared to a current price of Rp336.00 — trading 5.3% below its estimated fair value. The current Cash Flow from Financing is Rp-131,729 Mil. PTrana Meditama Metropolitan Tbk's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For PTrana Meditama Metropolitan Tbk (ISX:SAME), the current Cash Flow from Financing is Rp-131,729 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PTrana Meditama Metropolitan Tbk (ISX:SAME) Overvalued in 2026?
Based on GuruFocus' analysis, PTrana Meditama Metropolitan Tbk stock appears to be undervalued.
The current stock price of Rp336.00 is trading 5.3% below its estimated GF Value™ of Rp354.65.
GuruFocus considers PTrana Meditama Metropolitan Tbk to be Fairly Valued.
Key valuation signals for ISX:SAME:
Cash Flow from Financing: Rp-131,729 Mil
GF Value™: Rp354.65 vs. price of Rp336.00 (5.3% below fair value)
No single metric tells the full story. See the ISX:SAME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Sarana Meditama Metropolitan Tbk is engaged in managing hospitals. Its hospitals are operated under the brand name Omni Hospital. The company manages and evaluates its business based on its geographic location consisting of Omni Pulomas, Omni Alam Sutera, Omni Cikarang, OMNI Pekayon, and others. It operates in Banten, DKI Jakarta, and West Java.
64GF Score
Get the complete analysis for ISX:SAME
Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SAME has been successfully added to your 
